X. Liang

发表

Impact of Gender on the Prognosis of Patients with Hepatocellular Carcinoma After Palliative Therapy

Haotian Liu, J. Zhong, B. Xiang, 2021, Eurasian Journal of Medicine and Oncology.

Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2022, Frontiers in Oncology.

Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2021, Journal of Cancer.

Association between Single-Nucleotide Polymorphism in MicroRNA Target Site of DDB2 and Risk of Hepatocellular Carcinoma in a Southern Chinese Population

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2020, BioMed research international.

Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma

Xianguo Zhou, Zixiong Zhou, J. Zhong, 2019, Cancer medicine.

Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation

Xianguo Zhou, Hongping Yu, Mengyun Wang, 2020, Scientific Reports.

Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice

Wei Wei, Lequn Li, J. Zhong, 2021, Cancer Immunology, Immunotherapy.

A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2020, Human genomics.

Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics

Huan Wang, Shan Huang, X. Liang, 2020, OncoTargets and therapy.

A functional variant in the RAD51 3' UTR is associated with survival of hepatocellular carcinoma patients.

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2020, Gene.

Dose–Response Between Serum Prealbumin and All-Cause Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma

Haotian Liu, Lequn Li, J. Zhong, 2021, Frontiers in Oncology.

Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2023, Archives of Toxicology.

Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV‐related hepatocellular carcinoma survival

Xianguo Zhou, Hongping Yu, Zihan Zhou, 2023, Molecular carcinogenesis.

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC

Lequn Li, J. Zhong, Kang Chen, 2022, Frontiers in Oncology.

Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study

J. Zhong, Shan Huang, Kang Chen, 2023, Journal of Gastroenterology.

Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy

Haotian Liu, B. Xiang, Lequn Li, 2020, Journal of clinical and translational hepatology.

Genetic association of cardiovascular disease related biomarkers with the overall survival of hepatocellular carcinoma: a Mendelian randomization analysis.

Xianguo Zhou, Zihan Zhou, Yanji Jiang, 2023, American journal of cancer research.